Member Info for dougerboy

Not sure I understand your question AJP - but I do wish gazillions more would wish to buy into the story the LTH’s are committed to.

Thanks AJP. I’ve looked hard too but no joy, unless they’re procuring from within the US…

We are now in a really important growth phase where patience finally deserves to be rewarded - and happy for that to be the incremental or transformational. C’mon John!!

FB, looks like your recent purchase was inspired! I’m crossing everything that we are on a superhighway to days of old.

Anyone been able to access IA raw material import data to Itaconix for Q422 and Q123? Year on year growth would be interesting to see.

Well hindsight is a great thing Smart. I rode the price up - and stayed - all the way to 16p and am still here at 5! The difference now is we are further along the sales curve, new investors have stumped up a chunk of cash, presumably because of their better view (than ours) of a five year window (my assumption) of profitable revenue growth. The questions I ask myself are similar to yours. I’ll be here a while longer yet. Industrial ingredient dislocation takes more time than a lot of us would like I guess, but it’s still a compelling story for me here.

Yep, pretty much steady as she goes! Still a decent dividend and cautious optimism for the future, so looks like I’ll stick around a while longer!

Excess capital expenditure is carried forward as unredeemed capital to be claimed from future mining taxable income. So I see that as positive.

An interesting finish to the day FB! At this rate I might join you with an additional purchase. A share which has done nothing for so long - apart from decline! yet still produces a decent divi, has attracted consistent chunky purchases over the past days.

Yep me too. Wierd. I haven’t given up completely that something might be coming, before it retraces!

Another dart in the board this morning; not a bullseye by any stretch, but Frost&Sullivan are one of the world leaders in industry research and big industry often uses their expertise to assist in strategy formulation. This award will get noticed.

This is very positive news Smart. I wonder how long they plan on being on-board for? If they‘ve invested the bulk of the £10M, I Wonder how many multiples thereof do they expect to see that turn into, and within what timeframe.

Good idea WB. I took up the offer, so I’m happy to have a bit more flesh on the bones on the £10.5M strategic investment direction, for example the expected payback period on that. The big contributors presumably have the inside track on that - so unless there is proprietary customer 1st mover stuff curtailing wider dissemination, It would be nice to know! Let us know how you get on.

Well done FB I’m sitting on the fence, something definitely on the cards - hoping for something substantial versus a SP manipulation.

A Post without comment and/or basis of analysis. I hate that. Please give some context. Thanks. DB.

“Beyond market expectations”
I am part of the market with my small (significant for me) shareholding and my expectation (or hope!) for 2022 was $7M. I really believe we are on the cusp of something but by way of criticism of the management team, they can’t always harp on about TAM’s and SAM’s in the BILLIONS in the markets they are going after (correctly in my view) withou relativising (if that’s a word) that with a bit more specificity on their profitable growth plans. Which, to be fair, I guess they are trying the do with the Finncap notes. JS is conservative by nature, but c’mon John, drop a bombshell, rocket when the time is right!

Another thought on this: the RNS & Broker note mentions $1.9M OPex/Capex for 2023 and $3.6M Capex (no OPex) for 2024. An Interesting distinction, where the OPex part this year, to me, may well mean people Investment to run new plant capacity (Capex), wherever that may be.

I’ll plumb for Holland or Germany - loads of Pharm & Chemical Industry there.

If that’s the case, Co-locating onto a strategic customer/supplier site has merit. I remember John saying a future vision would be a strategic location in Europe for producing Itaconic Acid. Maybe the capital spend is to vertically integrate…

Exciting times ahead.

Nicely summarised Smudge! I’m looking forward to hearing what the Capital Spend will be on. It all sounds very promising. On the runway and the throttle levers are being pushed forward.

Well, that covered a lot of bases. A 3.6M capital spend sounds intriguing. I remember JS saying in previous presentations saying to expand existing facilities is relatively low cost Capex (ca. 0.5M?) so this sounds more substantial. Maybe a capital investment in a JV manufacturing partner. Time will tell. Either way it is very encouraging the management team is looking way down the tracks and can see what is coming. Good also that the contingent consideration is out of the way, with Yvon Durant getting shy of 2M shares. JS and his team can now really concentrate on rolling out (hopefully!) lots of good news. BIoAsterix, superabsorbents, coatings inter alia.